| Literature DB >> 1404301 |
H G Artman1, C A Morris, A D Stock.
Abstract
A patient is described with 18p- syndrome and hypopituitarism. This is the first patient with this syndrome who has been shown to benefit from growth hormone therapy. Patients with this syndrome who have growth deficiency should be considered for evaluation for hypopituitarism, if the quality of their lives would improve with an increase in stature.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1404301 PMCID: PMC1016104 DOI: 10.1136/jmg.29.9.671
Source DB: PubMed Journal: J Med Genet ISSN: 0022-2593 Impact factor: 6.318